En
Da
Fr
De
Sv
Deal History
About us
The Company
Team
Offices
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
En
Da
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
05 Apr 2024
Equity Research Kancera: Rights issue extends run-way at a crucial stage
Equity Research
Kancera
31 Jan 2024
Carlsquare Equity Research: Biotech snapshot Q4
Equity Research
Kancera
26 Jan 2024
Equity Research, Kancera: Focus on licensing
Equity Research
Kancera
04 Dec 2023
Equity Research Update Kancera, Q3 2023: Pending decisive outcome
Equity Research
Kancera
31 Oct 2023
Analyzing Nordic Biotech: News, Performance, Valuations, Big Pharma, Deals and Future Catalysts
Equity Research
Kancera
22 Sep 2023
Carlsquare Equity Research: Nordic Life Science sector update
Equity Research
Kancera
22 Aug 2023
Equity research update Kancera: Heart infarction results expected soon
Equity Research
Kancera
26 Apr 2023
Mrkt BUZZ, Kancera: Starting cancer trial
Equity Research
Kancera
15 Mar 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
Kancera
20 Feb 2023
Carlsquare Equity Research Nordic Life Science sector update
Equity Research
Abera Bioscience
03 Feb 2023
Mrkt BUZZ Kancera: Fractalkine project towards new milestones
Equity Research
Kancera
24 Oct 2022
Initiation of Coverage, Kancera: Expands the clinical program
Equity Research
Kancera
